These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 300885)
41. [Ground rules in pharmacotherapy of rheumatic diseases]. Wessel G; Reinicke C Z Gesamte Inn Med; 1980 Nov; 35(22):suppl 157-60. PubMed ID: 6970456 [No Abstract] [Full Text] [Related]
43. The cardiovascular system in rheumatic disease: the newest "extraarticular" manifestation? Solomon DH; Goodson NJ J Rheumatol; 2005 Aug; 32(8):1415-7. PubMed ID: 16078312 [No Abstract] [Full Text] [Related]
44. [What are the indications for non-steroidal anti-inflammatory agents in dermatology?]. Bonnetblanc JM Ann Dermatol Venereol; 1999; 126(8-9):649-52. PubMed ID: 10530363 [No Abstract] [Full Text] [Related]
45. [Synopsis of rheumatology]. Moll W Prog Drug Res; 1968; 12():165-291. PubMed ID: 4892527 [No Abstract] [Full Text] [Related]
47. [What shall we do with the numerous new anti-rheumatics?]. Hvidberg E Ugeskr Laeger; 1981 Apr; 143(16):1040-3. PubMed ID: 6972112 [No Abstract] [Full Text] [Related]
48. [NSAIDs: a clinical pharmacological determination of their role in the drug treatment of rheumatic disorders]. van Riel PL Ned Tijdschr Geneeskd; 1988 Nov; 132(48):2187-92. PubMed ID: 3264601 [No Abstract] [Full Text] [Related]
49. Immunosuppressive agents and nonsteroidal anti-inflammatory drugs for ocular immune and inflammatory disorders. Hemady RK; Chan AS; Nguyen AT Ophthalmol Clin North Am; 2005 Dec; 18(4):511-28, vi. PubMed ID: 16314216 [TBL] [Abstract][Full Text] [Related]
50. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases. Gibofsky A J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424 [TBL] [Abstract][Full Text] [Related]
51. Asymptomatic and symptomatic gastroduodenal patients affected by rheumatic disease treated with non-steroidal anti-inflammatory drugs. Magarò M; Altomonte L; Zoli A; Mirone L; Berchicci MC; Tricerri A; Corvino G Panminerva Med; 1989; 31(1):16-8. PubMed ID: 2786181 [TBL] [Abstract][Full Text] [Related]
52. [Nonsteroidal antirheumatics in soft tissue rheumatic diseases. Scientific background and differential therapy. 5th Rottach-Egern rheumatism discussion. 26 November 1988. Abstracts]. Fortschr Med Suppl; 1989; 60():1-11. PubMed ID: 2786832 [No Abstract] [Full Text] [Related]
53. Drug use in rheumatic disease. Silman AJ Practitioner; 1988 Nov; 232(1458):1204-7. PubMed ID: 3076958 [No Abstract] [Full Text] [Related]
56. [Use of anti-inflammatory drugs in children]. Hoppu K; Korpela R Duodecim; 1994; 110(6):607-14. PubMed ID: 7555861 [No Abstract] [Full Text] [Related]
57. Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute couture. Cronstein BN Nat Clin Pract Rheumatol; 2006 Jan; 2(1):2-3. PubMed ID: 16932642 [No Abstract] [Full Text] [Related]
58. Is there anything else we could possibly need to know about COX-2 selective inhibitor drugs? Davis P; Juby A; Robertson S; Richard N J Rheumatol; 2004 May; 31(5):847-8. PubMed ID: 15124241 [No Abstract] [Full Text] [Related]
59. Drug therapy in the rheumatic diseases. Reardon EV; Clough JD Compr Ther; 1992 Nov; 18(11):22-5. PubMed ID: 1478055 [No Abstract] [Full Text] [Related]
60. [The introduction of non-steroidal antirheumatics: is there a rational therapy]. Schlumpf U Schweiz Med Wochenschr; 1982 Aug; 112(35):1200-8. PubMed ID: 6753142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]